In summary, we show that Wnt5a, initially studied for its role in tumor migration and invasion, activates NF-κB and exerts an immunomodulatory role, further establishing Wnt5a as a promising therapeutic target for melanoma. This evidence concerns the gene NFKB1 and melanoma.